Tom Spalding | Head of Products, Pipeline and Strategy | Takeda Oncology

Tom Spalding is Head of Global Oncology Products and Pipeline Strategy for Takeda in the Oncology Business Unit, where he leads global marketing, new product planning, search and evaluation, insights and analytics, and strategic operations. In this role, Tom oversees the strategic direction and commercial development of Takeda’s oncology portfolio and pipeline, spanning across a range of oncology therapeutic areas.

Prior to joining Takeda, Tom served as Vice President of Oncology, Global Marketing and Commercial Operations at AbbVie, where he played an instrumental role in building and expanding the company’s oncology presence. During his 11-year tenure, he successfully drove strategies for both late-stage and on-market pipeline assets, significantly contributing to the growth of AbbVie’s oncology franchise. As Chief Commercial Officer at Caris Life Sciences, Tom led global commercial operations for this innovative oncology biotech company, managing full P&L responsibilities. His career began at Johnson & Johnson, where he progressed through successive leadership roles in Sales, Sales Management, and Marketing across multiple therapeutic areas and geographies, building a strong foundation in commercial strategy and execution.

Tom holds an MBA from Boston College Carroll School of Management and a BA from the College of the Holy Cross. Based in Cambridge, Massachusetts, Tom serves as a member of Takeda’s Oncology Leadership Team.